Salofalk: ntuziaka maka ojiji

"Salofalk" kandụl - German ọgwụ mmepụta, itinye na prophylaxis na ọgwụgwọ nke ọnyá afọ ná mgbanwe nke n'ogo na Crohn oria. Isi nọ n'ọrụ mgwa, nke bụ akụkụ nke kandụl "salofalk" bụ mesalazine.

Ọgwụ "salofalk" na pharmacies nwere ike dị na ndị na-esonụ onunu ogwu iche:

• rectal suppositories (kandụl);
• nkwusioru rectal na onu nkwusioru;
• mbadamba (ntekwasa dissolves na eriri afọ ma ọ bụ ruo ogologo oge edinam).

Họrọ a onunu ogwu ụdị pụtara "salofalk" nduzi tụrụ aro na-elekwasị anya orunótu, nakwa dị ka nsia lesion ebe. N'ihi na ọgwụgwọ nke ọrịa Nleta distal atụ aro rectal iche-iche, suppositories mma ojiji na ọgwụgwọ nke nkịtị iche nke ọrịa. Akawanye njọ nke ọrịa a ga-emeso ya na "salofalk" erikpu ruo 800 mg, na-ewere ya ugboro atọ n'ụbọchị. Iji gbochie nlọghachi azụ - 500 mg nke ọgwụ, na ugboro 3 bụrụ nke ọnyá afọ, nonspecific. Mgbe Crohn ọrịa kwesịrị iwere na ọ bụghị ihe karịrị 1 g 4 ugboro n'ụbọchị. Oké ọrịa na-eme na-abawanye doses ruo 4 grams kwa ụbọchị. Otú ọ dị, oge nke ndị dị otú ahụ ọgwụ ekwesịghị gafere 12 izu.

Oral mbadamba ga-elo mgbe a nri, na-enweghị ịta, ya na a zuru ezu ego nke mmiri mmiri. Ọgwụ "salofalk" (kandụl) ntuziaka tụrụ aro na-enweghị ihe karịrị 500 mg, ugboro 3 a ụbọchị; slurry - bụghị ihe karịrị 60 g ugboro tupu alakpu ụra dị ka microclysters (mma tupu kpochara eriri afọ). Ụmụ ọhụrụ kwesịrị iwere 60 mg kwa 1 n'arọ nke ahu arọ kwa ụbọchị na exacerbation nke ọrịa, iji kpochapụ omume nlọghachi azụ - 30 mg kwa 1 n'arọ nke ahu aro. Ọzọkwa, otu ugboro n'ụbọchị.

Otu n'ime ihe ndị ọgwụ Njirimara nke ọgwụ "salofalk" ntụziaka a na-akpọ a local mgbochi mkpali, antibacterial na antioxidant mmetụta.

Were "salofalk" na-atụ aro bụrụ na ọrịa bụ ugbu site na ndepụta:

• kwere omume anabata salicylic acid nkwekọrịta;
• akụrụ na imeju na nnukwu ogbo;
• ọnyá ọrịa nke afo na duodenum;
• lactation na ikpeazụ trimester nke dị ime;
• ụmụ n'okpuru afọ 24 ọnwa;
• ọbara ọrịa nke iche iche iche iche.

N'ihu iji ngwaahịa "salofalk" nduzi na-atụ aro familiarizing na ndepụta nke o kwere omume mmetụta:

• afọ ọsịsa, vomiting, ọgbụgbọ, ihe mgbu ke afo, na dị iche iche na nsogbu iri nri, pancreatitis, ịba ọcha n'anya;
• iku ume ọkụ ọkụ, ngwa ngwa mgbanwe ọbara mgbali, tachycardia;
• ịda mbà n'obi, tinnitus, dizziness;
• anuria, hematuria, nephrotic syndrome;
• akpụkpọ rashes, dermatitis, pruritus;
• eosinophilia, leykopiniya, anaemia;
• oligospermia, volchanopodobny syndrome, ike ọgwụgwụ, alopecia, mumps.

Ke ofụri ofụri, ọgwụ nwere elu tolerability ma mmetụta na-eleghi anya.

Ke adianade do, ọ na-atụ aro na-ekwenye na kwuru doses anata ntụziaka, ma ọ bụghị dị mgbe eji overdoses nke ọgwụ "salofalk" (kandụl). Ya mgbaàmà bụ:

• n'adịghị ike anyị;
• ọgbụgbọ;
• iro ụra;
• gastralgia;
• vomiting.

N'ihe banyere nchọpụta ndị a mgbaàmà maka ozugbo ọgwụgwọ kwesịrị ịkpọ onye dọkịta: gastric lavage, ojiji nke laxatives.

Mgbe anata ndị dị otú ahụ ọgwụ ọjọọ eme ihe dị ka "salofalk" ntụziaka na-achọ na-ebu a mgbe nile analysis nke ọbara na mmamịrị, iji gbochie mmepe nke nsogbu. Ke adianade do, e nwere mmamịrị na dọkatụrụ adọka ọmụmụ ihe ize ndụ nke agba oroma. Na otu ngafe n'ikuku "salofalk" na-atụ aro na-Agbaghara dose na-ọzọ. Ugboro ugboro awụgharị ọgwụ ga-eme ka discontinuation nke ọgwụgwọ na-achọ ọgwụ na ntị.

Ozi bụ exploratory ke uwa. Biko adịghị onwe-medicate. Tupu iji, ịga hụ dọkịta.